Abstract
A series of cyclometallated mono- and di-nuclear platinum(II) complexes and the parent organic ligand, 2,6-diphenylpyridine 1 (HC^N^CH), have been synthesized and characterized. This library of compounds includes [(C^N^C)Pt(II)(L)] (L = dimethylsulfoxide (DMSO) 2 and triphenylphosphine (PPh3) 3) and [((C^N^C)Pt(II))2(L`)] (where L` = N-heterocycles (pyrazine (pyr) 4, 4,4,`-bipyridine (4,4`-bipy) 5 or diphosphine (1,4-bis(diphenylphosphino)butane (dppb) 6). Their cytotoxicity was assessed against four cancerous cell lines and one normal cell line, with results highlighting significantly increased antiproliferative activity for the dinuclear complexes (4-6), when compared to the mononucleated species (2 and 3). Complex 6 is the most promising candidate, displaying very high selectivity towards cancerous cells, with selectivity index (SI) values > 29.5 (A2780) and > 11.2 (A2780cisR), and outperforming cisplatin by > 4-fold and > 18-fold respectively.
Original language | English |
---|---|
Pages (from-to) | 14938-14946 |
Number of pages | 9 |
Journal | Chemistry - A European Journal |
Volume | 26 |
Issue number | 65 |
Early online date | 10 Jun 2020 |
DOIs | |
Publication status | Published - 20 Nov 2020 |
Keywords
- anticancer
- bioinorganic chemistry
- cyclometallated platinum(II)
- multinuclear complexes
- phosphine ligands
Profiles
-
Rianne Lord
- School of Chemistry, Pharmacy and Pharmacology - UKRI Future Leaders Fellow
- Centre for Molecular and Structural Biochemistry - Member
- Chemistry of Life Processes - Member
- Chemistry of Materials and Catalysis - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching & Research